acth-(4-7)--pro-gly-pro- and Reperfusion-Injury

acth-(4-7)--pro-gly-pro- has been researched along with Reperfusion-Injury* in 2 studies

Other Studies

2 other study(ies) available for acth-(4-7)--pro-gly-pro- and Reperfusion-Injury

ArticleYear
Brain Protein Expression Profile Confirms the Protective Effect of the ACTH
    International journal of molecular sciences, 2021, Jun-08, Volume: 22, Issue:12

    The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide enhanced the transcription of neurotrophins and their receptors and modulated the expression of genes involved in the immune response. A genome-wide RNA-Seq analysis revealed that, in the rat transient middle cerebral artery occlusion (tMCAO) model, Semax suppressed the expression of inflammatory genes and activated the expression of neurotransmitter genes. Here, we aimed to evaluate the effect of Semax in this model via the brain expression profiling of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as neuroprotection and recovery (CREB) in stroke. At 24 h after tMCAO, we observed the upregulation of active CREB in subcortical structures, including the focus of the ischemic damage; downregulation of MMP-9 and c-Fos in the adjacent frontoparietal cortex; and downregulation of active JNK in both tissues under the action of Semax. Moreover, a regulatory network was constructed. In conclusion, the suppression of inflammatory and cell death processes and the activation of recovery may contribute to the neuroprotective action of Semax at both the transcriptome and protein levels.

    Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Ischemia; Disease Models, Animal; Male; Neuroprotective Agents; Peptide Fragments; Proteome; Rats; Rats, Wistar; Reperfusion Injury; RNA-Seq; Transcriptome

2021
Novel Insights into the Protective Properties of ACTH
    Genes, 2020, 06-22, Volume: 11, Issue:6

    Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH

    Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Ischemia; Disease Models, Animal; Humans; Infarction, Middle Cerebral Artery; Peptide Fragments; Rats; Reperfusion Injury; RNA-Seq; Transcriptome

2020